SCHEMBL6676594

SCHEMBL6676594

CCOC(=O)c1ccc(S(=O)(=O)c2ccc(OCCNC(Cc3ccccc3)[C@H](O)c3cccc(Cl)c3)cc2)cc1

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ADRB3 P13945 11/20 0.42
ADRB2 P07550 8/20 0.42
ADRB1 P08588 8/20 0.42
CYP2D6 P10635 2/20 0.42
ADRA1D P25100 1/20 0.42
ADRA1A P35348 1/20 0.42
ADRA1B P35368 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
SLC2A1 P11166 2/20 0.42
TP53 P04637 1/20 0.41
CYP3A4 P08684 1/20 0.41
HIF1A Q16665 1/20 0.41
GLA P06280 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
MAOB P27338 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6681939 0.90 ADRB3 (0.38) ADRB3ADRB2ADRB1CYP2D6ADRA1D
SCHEMBL6676623 0.87 ADRB3 (0.52) ADRB3ADRB2ADRB1CYP2D6ADRA1D
SCHEMBL6677875 0.87 ADRB3 (0.43) ADRB3ADRB2ADRB1CYP2D6ADRA1D
SCHEMBL6683325 0.85 ADRB3 (0.43) ADRB3ADRB2ADRB1CYP2D6ADRA1D
SCHEMBL6678008 0.84 ADRB3 (0.41) ADRB3ADRB2ADRB1CYP2D6ADRA1D
SCHEMBL6677081 0.83 CYP4F2 (0.42) ADRB3ADRB2ADRB1TP53
SCHEMBL6680801 0.83 ADRB3 (0.46) ADRB3ADRB1SLC2A1
SCHEMBL6677033 0.81 ADRB3 (0.44) ADRB3ADRB2ADRB1
Hydrochloric Acid SCHEMBL6806270 0.81 ADRB3 (0.56) ADRB3ADRB1SLC2A1
Hydrochloric Acid SCHEMBL6676618 0.81 ADRB3 (0.56) ADRB3ADRB1SLC2A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004045610-A1 AMINOALCOHOL DERIVATIVES AND THEIR USE AS BETA-3 ADRENERGIC RECEPTOR AGONISTS FUJISAWA PHARMACEUTICAL CO., LTD (JP) 2004-06-03 WO disclosed